Needle biopsy of the parietal pleura was undertaken in 64 patients with undiagnosed pleural effusion. An adequate specimen was obtained in 96% of procedures. This was diagnostic in 45 % of those due to malignancy and in 50 % of those due to tuberculosis. A second biopsy improved the combined diagnostic yield in these two diseases from 32% to 46%. Pleural fluid cytology was unhelpful in establishing the presence of a malignancy, and culture of the biopsy specimen was helpful in one case. INTRODUCTION Pleural disease is a common clinical problem. The pleural space may be involved in many diseases, and establishing a diagnosis may prove difficult. Needle biopsy of the parietal pleura was introduced by DeFrancis in 1955 and this proved to be an important advance.' There have since been a number of reports which have discussed the technique, indications, complications and diagnostic accuracy of closed pleural biopsy, with a comprehensive review by Light.2 We report our experience of the diagnostic value of needle biopsy of the parietal pleura.
RESU LTS
A single biopsy procedure was carried out on 47 patients (73%) and a second biopsy on 15 (23%). The remaining two patients had four and five biopsies respectively. An adequate specimen suitable for histological examination was Needle biopsy of pleura obtained in 81 of 84 procedures (96%). The most common final diagnosis was malignancy in 31 patients (48%). In 20 patients (31 %) the pleural effusion was associated with underlying pneumonia, and tuberculosis was diagnosed in six patients (9%). There were three patients with congestive cardiac failure and persistent pleural effusion which led to evaluation for coexistent pathology, all of whom eventually responded to diuretic therapy. Single cases of pleural involvement with rheumatoid disease, sarcoidosis and an empyema were found. No diagnosis was made in one patient lost to follow-up. In the malignant group, out of a total of 31 patients, 14 had diagnostic histology and one was 'probable'. Fifteen showed non-specific fibrosis or inflammation, and no pleura was identified in one. The primary site was bronchus in 18 patients (58%), breast in three, ovary or uterus in two, gastrointestinal tract in two, lymphoma in two, prostate in one, and in three patients was unidentified. Of the 20 patients in the para-pneumonic group, the biopsy specimen in 19 showed non -specific changes and in one no pleura was identified. All responded satisfactorily to antibiotic treatment. In the six patients with tuberculous effusion, three biopsies were positive and three showed non -specific fibrosis or inflammation. All these patients were Heaf positive grade 3 or 4, and subsequently had a satisfactory clinical and radiological response to anti-tuberculous treatment. Seventeen patients had a second biopsy procedure. There were 10 in the malignant group, of whom four were diagnostic, and two in the tuberculous group, one being positive. The patient with sarcoidosis had four biopsies in close succession, the second being diagnostic. One patient, who had five biopsies, all of which proved negative, died of his primary abdominal neoplasm three months later. Pleural fluid was examined cytologically in 26 patients with a malignancy, but malignant cells were seen in only three cases (11 %), and in two of these the pleural histology was also positive. Uniformly bloodstained fluid was found in 35% of those with malignancy, 20% of the para-pneumonic group, 50% of those with tuberculosis and in the patient with sarcoidosis. The procedure was well tolerated. Pneumothorax occurred after four procedures, one requiring tube drainage. Needle track seeding of tumour occurred in one patient.
DISCUSSION
Needle biopsy of the parietal pleura remains a useful and safe procedure in exudative effusion. No serious complications occurred. Pneumothoraces, large enough to require tube drainage, have been reported in about 1 % of procedures3-5 and there was a similar rate in our series. The overall complication rate was 6 per cent. Three patients with transudates due to congestive cardiac failure had biopsies performed at the time of diagnostic thoracocentesis, which might have been avoided by estimation of the pleural fluid content at the bedside, using a refractometer.6 There had been a reversal in the incidence of the two most common causes of pleural exudates, tuberculosis and malignancy, since the introduction of closed pleural biopsy5-9 and this was reflected in our findings of 48 % malignant and 9 % tuberculous causation. The diagnostic return in malignant effusion compares favourably with that of previously reported series, 35 -75% in malignant effusion.'10-13 In this study only 11 % in this category had positive pleural fluid cytology, although the accuracy of cytological diagnosis has been reported as between 40% and 90%.13, 14 The various factors contributing to an optimal yield include the tumour type, number of specimens examined, the methods of examination employed and the skill of The Ulster Medical Journal the cytologist.2 In our experience, pleural biopsy was a much more reliable method of diagnosis than cytology, and this is likely to be the experience in other hospitals which do not have the services of a specialist cytologist. In the tuberculous group, 50% of biopsies were diagnostic, comparable to the yield of 38 to 71 % in other series.10-'9 The diagnostic yield was increased by culture of one of the specimens.16 A second biopsy procedure was worthwhile, increasing the diagnostic yield in the tuberculous and malignancy groups combined from 32 % to 46 %. Similar results have been reported, with improvement in the specific diagnosis from 40 % to 50 % with a second biopsy.'0 Non -specific changes were seen in 48 % of patients with malignancy in this study. This can be explained by the blind nature of the sampling technique employed, coupled with the patchy distribution of the disease on the pleura. 20 In addition, the pleura may not be directly involved, the effusion being caused by other mechanisms. Thoracoscopy has been advocated, especially in Europe, to overcome the problem of false negative biopsy, but at the expense of increased morbidity.2'
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